Cafepharma Today

September 19 2024 - Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
Havas Lynx explores pharma marketers’ role in addressing climate health crisis
Roche reports positive data from Phase III influenza treatment trial
ICER mulls GSK COPD drugs ahead of next Medicare negotiation
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Glaxo, Pfizer in HIV-Drug Unit Tie-Up: Report
TheStreet.com
Thursday, April 16, 2009 - 7:09am
tags:
GSK, Pfizer, HIV, partnerships, joint ventures
Roche beats recession in first quarter
Yahoo/Reuters
Thursday, April 16, 2009 - 7:08am
tags:
Roche, earnings, Genentech
J&J shelves plans for separate wellness unit: report
Yahoo/AP
Thursday, April 16, 2009 - 7:07am
tags:
JNJ
Marked Improvement Bodes Well for Pozen
Seeking Alpha
Wednesday, April 15, 2009 - 10:18pm
tags:
Pozen, Treximet, GSK
Study: Lilly bone drug boosts fracture-healing
Fierce Pharma
Wednesday, April 15, 2009 - 5:40pm
tags:
Eli Lilly, osteoporosis, Forteo
Carl Icahn calls on Amylin chairman to step down
Marketwatch
Wednesday, April 15, 2009 - 5:31pm
tags:
Carl Icahn, Amylin
A Big Upgrade for Forest Labs
Motley Fool
Wednesday, April 15, 2009 - 5:27pm
tags:
Forest Labs, Savella, Cypress Bioscience, Lexapro, Namenda
Abbott's on Sale
Motley Fool
Wednesday, April 15, 2009 - 5:26pm
tags:
Abbott Laboratories, JNJ, Amgen, Wyeth, Boston Scientific
Drug stocks dip; Infinity halted on drug trial news
Marketwatch
Wednesday, April 15, 2009 - 10:02am
tags:
Infinity, drug trials
Merck Exec on R&D: ‘Nothing Is Safe From Cuts’
WSJ Online
Wednesday, April 15, 2009 - 10:00am
tags:
Merck, R&D
Pfizer Top Pharma Social Brand
Media Post
Wednesday, April 15, 2009 - 9:25am
tags:
Pfizer, social media
Cancer pills suffer from red tape
Fierce Pharma
Wednesday, April 15, 2009 - 9:24am
tags:
cancer, insurance
Highlights from Day 1: Pharmaceutical Strategic Outlook Conference
InVivo
Wednesday, April 15, 2009 - 9:10am
tags:
J&J CFO Says Slump’s Effect on Company Won’t Worsen
Bloomberg
Wednesday, April 15, 2009 - 9:02am
tags:
JNJ
Merck licenses Santen eye drug for undisclosed sum
Yahoo/AP
Wednesday, April 15, 2009 - 8:58am
tags:
Merck, licensing, Santen, tafluprost
Sales of Abbott's Humira Shy Of Projections
TheStreet.com
Wednesday, April 15, 2009 - 8:40am
tags:
Abbott Laboratories, Humira, earnings
Abbott profit helped by special gains
Yahoo/Reuters
Wednesday, April 15, 2009 - 8:30am
tags:
Abbott Laboratories, earnings
After Falling for Fake Clinical Trial, Review Board Steps Aside
WSJ Online
Wednesday, April 15, 2009 - 8:17am
tags:
drug trials
P&G backs drug in deal to pay insurer
Yahoo/AP
Wednesday, April 15, 2009 - 8:11am
tags:
Proctor & Gamble, osteoporosis, Actonel
Sanofi-Aventis to Buy Cancer Drug Firm BiPar
TheStreet.com
Wednesday, April 15, 2009 - 7:29am
tags:
Sanofi, cancer, Bi-Par, buyouts, PARP inhibitors

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

FDA Approves Fasenra for Eosinophilic Granulomatosis with Polyangiitis
pharmexec
FDA Approves Keytruda Plus Pemetrexed, Platinum Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma
pharmexec
Keytruda Demonstrates Superior Overall Survival vs. Yervoy in Advanced Melanoma
pharmexec
CAR-T For Autoimmune Disorders
In the Pipeline
A Better Response to Inflammation: Q&A with Dr. Ira Spector
pharmexec
Braftovi Plus Mektovi Demonstrates Sustained Efficiency in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
pharmexec
GSK Launches Brooke Shields’ Led Campaign Promoting Shingles Vaccine
pharmexec
Pharma Pulse: 9/18/24: How Drug Shortages Affect Pharmacovigilance, Long Strange Trip Continues for Psychedelics & more
pharmexec
Pharmaceutical Executive: September 2024 Issue (PDF)
pharmexec

Latest Jobs

Account Manager-Los Angeles-Ophthalmics
Los Angeles, California, 90079
Sun Pharmaceutical Industries, Inc.
Regional Sales Manager - Eyecare - East Region
Miami, Florida, 33222
PV8 US Innovex Inc.
Business Development Manager- Tampa, Florida
Tampa, Florida, 33646
Hanger Clinic
Neuroscience Account Manager (Psychiatry) - Burbank, CA
Burbank, California, 91520
Vanda Pharmaceuticals
Territory Account Associate- Grand Rapids, MI
Grand Rapids, Michigan, 49528
Amplity Health
Surgical Solutions Field Sales Associate - Remote
Milwaukee, Wisconsin, 53244
W.L. Gore & Associates
Manager, Business Development - Physician Relations - Days - Full-Time
Baton Rouge, Louisiana, 70873
Woman's Hospital
Area Business Manager - Pulmonology - Greenville, SC
Asheville, North Carolina, 28814
Sanofi
Area Manager, Specialty Atlantic Region
Fields, Oregon, 97710
CSL Behring
Territory Manager (PCP) (Madison, AL)
Huntsville, Alabama, 35824
Bausch Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information